Hospitals in the Netherlands are increasingly concerned about the availability of various types of agents that form the basis ...

Around 2,400 people in England have ES-SCLC, of whom around 1,200 people will be eligible to receive Tecentriq plus carboplatin and etoposide. NICE noted that clinical trial evidence suggests ...

Durvalumab (Imfinzi) with etoposide and either carboplatin or cisplatin is available on the NHS. It is a possible treatment for extensive-stage small-cell lung cancer that has not been treated before ...

Finally, our studies of Spo11 have also provided an entry point to research on the DSBs made by the enzyme Topoisomerase II when it is inhibited by chemotherapeutic agents such as etoposide or ...

Most patients with metastatic germ cell tumors (GCTs) are considered to have a good prognosis: cure rates >90% have been reported since the introduction of bleomycin, etoposide and cisplatin (BEP ...